A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis

Author： Soon Derek Altmann Daniel Fernando Kryshani Giovannoni Garin Barkhof Frederick Polman Chris O’Connor Paul Gray Bruce Panzara Michael Miller David

Publisher： Springer Publishing Company

ISSN： 0340-5354

Source： Journal of Neurology, Vol.254, Iss.3, 2007-03, pp. : 306-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effects of adjunct glucosamine sulfate on relapsing–remitting multiple sclerosis progression: Preliminary findings of a randomized, placebo-controlled trial

By Shaygannejad Vahid Janghorbani Mohsen Savoj Mohammad Reza Ashtari Fereshteh

Neurological Research, Vol. 32, Iss. 9, 2010-11 ,pp. : 981-985

Maney Publishing

Access to resources Recommend Favorite

Brain atrophy in clinically early relapsing–remitting multiple sclerosis

By Chard D.T. Griffin C.M. Parker G.J.M. Kapoor R. Thompson A.J. Miller D.H.

Brain, Vol. 125, Iss. 2, 2002-02 ,pp. : 327-337

Oxford University Press

Access to resources Recommend Favorite

Short-term brain volume change in relapsing–remitting multiple sclerosis

By Rovaris M.

Brain, Vol. 124, Iss. 9, 2001-09 ,pp. : 1803-1812

Oxford University Press

Access to resources Recommend Favorite

A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis

By Vollmer T. Sorensen P. Selmaj K. Zipp F. Havrdova E. Cohen J. Sasson N. Gilgun-Sherki Y. Arnold D.

Journal of Neurology, Vol. 261, Iss. 4, 2014-04 ,pp. : 773-783

Springer Publishing Company

Access to resources Recommend Favorite

Specificity of frontal dysfunctions in relapsing – remitting multiple sclerosis

By Santiago O.

Archives of Clinical Neuropsychology, Vol. 22, Iss. 5, 2007-06 ,pp. : 623-629

Oxford University Press

Access to resources Recommend Favorite